logo
Select company
Select metric
$ 58.14MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
80
Sector
88
Industry
91
History
50
$ 22.06Close
$ 5.02 - $ 27.09 52-Week Range
Ticker Information

Ticker

SEPN

Company Name

SEPTERNA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SEPTERNA INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SEPN - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ 58.14M
12/31/2024$ 149.71M
12/31/2023$ 57.92M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SEPTERNA INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 57.92M.
  • Over the past 5 years, SEPTERNA INC's average CF - Chg. Cash has been $ 88.59M.
  • The median CF - Chg. Cash for SEPTERNA INC during this period was $ 58.14M
  • SEPTERNA INC reached its highest CF - Chg. Cash over the past 5 years at $ 149.71M.
  • The lowest CF - Chg. Cash recorded by SEPTERNA INC in the same timeframe $ 57.92M

SEPTERNA INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
PROK : PROKIDNEY CORP $ -129.57MHUMA : HUMACYTE INC $ -5.53MABEO : ABEONA THERAPEUTICS INC $ 129.11MMREO : MEREO BIOPHARMA GROUP PLC $ -33.82MCRDF : CARDIFF ONCOLOGY INC $ -14.72MNWBO : NORTHWEST BIOTHERAPEUTICS INC $ 1.44MRNAC : CARTESIAN THERAPEUTICS INC $ 73.16MVTGN : VISTAGEN THERAPEUTICS INC $ -53.93MRNXT : RENOVORX INC $ 572KATYR : ATYR PHARMA INC $ 10.4M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

SEPN - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ 57.92M

Minimum

Dec 31, 2023

$ 149.71M

Maximum

Dec 31, 2024

$ 88.59M

Average

$ 58.14M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M